Invest in

Biotech Breakthroughs

5.5%
1.8%
0.0%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
5.5%
1.8%
0.0%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
36.1% Cancer 17.6%
19.0% Amgen Inc. AMGN 13.7%
15.1% Celgene Corporation CELG 20.5%
1.0% SciClone Pharmaceuticals Inc. SCLN 1.4%
1.0% Seattle Genetics Inc. SGEN 68.5%
17.4% Other Diseases 2.9%
6.1% Regeneron Pharmaceuticals Inc. REGN 1.9%
4.9% Alexion Pharmaceuticals Inc. ALXN 12.5%
3.6% Vertex Pharmaceuticals Incorporated VRTX 3.1%
1.9% United Therapeutics Corporation UTHR 9.3%
0.9% Acorda Therapeutics Inc. ACOR 6.3%
16.7% Autoimmune Disorders 30.1%
8.5% Biogen Inc. BIIB 6.3%
3.9% Incyte Corporation INCY 103.6%
3.3% BioMarin Pharmaceutical Inc. BMRN 4.3%
1.0% Rigel Pharmaceuticals Inc. RIGL 31.4%
16.0% Research & Diagnostics 13.2%
6.8% Quintiles IMS Holdings Inc. Q 19.3%
3.4% Illumina Inc. ILMN 4.6%
2.9% Charles River Laboratories International Inc. CRL 17.8%
1.8% Bio-Techne Corp TECH 9.2%
1.0% Luminex Corporation LMNX 5.2%
13.8% Infectious Diseases 25.1%
12.8% Gilead Sciences Inc. GILD 25.8%
1.0% Emergent Biosolutions Inc. EBS 16.0%

Quotes delayed 15 mins. Currently Mar 23, 2017 4:10:04 AM. Fields are marked with -- when data is unavailable.